Randall Stanicky Recent News
RBC Analyst Says 'Buy The Spread' On Allergan-Pfizer Deal
RBC: Neos Therapeutics Has 70% Upside, $500 Million Opportunity
Depomed Rejected Horizon Pharma's Takeout Bid, But Still Trades As If M&A Is Happening
RBC Says Stay Away From Mylan, Perrigo; Go Long Teva, Allergan
RBC Capital Downgrades Allergan, But Still Keeps It As 'Core' Holding
Eagle Pharma Has 'Several Upcoming Catalysts' And Is A Buy, RBC Says
UPDATE: Canaccord Genuity Raises PT on Perrigo on Attractive Medium-Term Opportunities
UPDATE: Canaccord Genuity Lowers PT on Allergan on Disappointments Hitting Sentiment
Goldman Sachs Calls Allergan (AGN) Top Idea
Goldman Sachs Lowers Medicis Pharmaceutical (MRX) Price Target
FDA Denies Teva Pharmaceutical (TEVA) Citizen Petition